Acknowledgements
BANNISTER, STUART, INFECTIOUS
The authors would like to thank the members of the Safety Monitoring Committee (W. Henry Boom, Fiona Smaill, and Kathleen M. Neuzil), the Independent Safety Monitors (John Richart and Marie Philipneri), and the Medical Monitor (Stuart Kahn) for their excellent oversight and feedback. The authors also wish to thank our colleagues from the Division of Microbiology and Infectious Diseases/NIAID/National Institutes of Health (NIH) for helpful and engaged discussions and project management, including Larry Wolfraim, Carol Ostrye, Onyinye Erondu, Mohamed M. Elsafy, Mamodikoe Makhene, Jonathan McInnis, Michelle Wildman, and Kamal Velmurugan. The authors are also grateful for project management and administrative assistance from Prerana Ranjitkar, Elyse Beebe, Sandra Sivananthan, Elise Larson, Jannabeth Bannister, and Tre Argerious; and editorial assistance from Valerie Soza. This work was supported by federal funds from NIAID, NIH, Department of Health and Human Services, under Contract #HHSN272201400041C (CBF). NIAID participated in study design, analysis, and manuscript writing.